Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Irritant potential of Acanya Gel vs Epiduo Gel on acneic facial skin (split-face, 14 days)
2010-020796-24Phase 4Terminated
- Sponsor
- Dow Pharmaceutical Sciences
- Start
- Aug 2010
- Modality
- Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial in acne vulgaris comparing Acanya Gel side of face with Epiduo Gel side of face (2 arms). Primary endpoint: Irritant potential assessment. Started Aug 2010; status: terminated.
02
Drugs
clindamycin + benzoyl peroxideadapalene
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on 2010-020796-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020796-24.